Catharina Hospital in Eindhoven, Netherlands, has bought the MRIdian Linac MRI-Guided Therapy System from ViewRay.

The device combines the innovations in precision radiation delivery and MR-guidance.

Also called Catharina Ziekenhuis, Catharina Hospital is said to be the biggest hospital in the region and provides ‘leading experience in cardiovascular care and oncology’.

Catharina Hospital leading radiation oncologist Peter-Paul van der Toorn said: “We believe adding MRIdian to our extensive portfolio of cancer treatments will improve the quality of care we can provide for our patients.

“Through the use of MRI-guidance and on-table adaptive capabilities, we can improve the accuracy with which we deliver radiation, deliver higher doses in fewer treatment sessions, and reach tumours that were otherwise virtually unreachable.”

MRIdian combines MRI system with a radiation therapy system, which is said to provide benefits in the delivery of safe and effective radiotherapy.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

These include the ability to see the tumour and tissue around it, the adaptation of the therapy in response to changes in patient anatomy and tumour size between treatments.

Other benefits include continuous tracking of the tumour during treatment, and automatic pausing of the radiation if the tumour moves outside of the boundary.

With this, the system provides the tumour with ablative, high-dose radiation while safeguarding the surrounding healthy tissue.

ViewRay Sales and Marketing senior vice-president Paul Ziegler said: “We are pleased to welcome Catharina Hospital to our family of centres integrating MRIdian into their radiation oncology programme.

“They have a proven clinical pedigree in effectively treating historically difficult to treat tumours and we believe MRIdian will be the perfect complement to that expertise.”